Skip to main content
SpringerLink
Log in

Pharmacoeconomic Considerations in Antiarrhythmic Therapy

  • Review Article
  • Published:
PharmacoEconomics Aims and scope Submit manuscript

Summary

Recently, the Cardiac Arrhythmia Suppression Trial (CAST) has focused attention on the morbidity and mortality that may be associated with pharmacological antiarrhythmic therapies. While the severity and frequency of adverse effects vary among the available agents, it is uncertain whether initial therapy with one agent is preferable to that with another when efficacy, incidence of adverse effects and costs of treating these adverse effects are examined. Moreover, it is uncertain whether pharmacotherapy is more cost-effective than other strategies.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Anderson MH, Paul VE, Jones S, Ward DE, Camm AJ. Transtelephonic interrogation of the implantable cardioverter defibrillator. Pacing and Clinical Electrophysiology 15: 1144–1150, 1992

    Article  PubMed  CAS  Google Scholar 

  • Anderson MH, Camm AJ. The automatic implantable defibrillator in a society with limited resources. Cardiovascular Journal of South Africa 2: 82–84, 1991

    Google Scholar 

  • Beck JR, Salem DN, Estes NAM, Pauker SG. A computer-based Markov decision analysis of the management of symptomatic bifascicular block: the threshold probability for pacing. Journal of the American College of Cardiology 9: 920–935, 1987

    Article  PubMed  CAS  Google Scholar 

  • Beck JR, Pauker SG. The Markov process in medical prognosis. Medical Decision Making 3: 419–458, 1983

    Article  PubMed  CAS  Google Scholar 

  • Bigger JT, Hoffman BF. Antiarrhythmic drugs. In Gilman et al. (Eds) The pharmacological basis of therapeutics, 6th ed., p. 768, Macmillan Publishing Company Incorporated, New York, 1980

    Google Scholar 

  • Buxton MJ, O’Brian BJ, Rushby JA. Cost-effectiveness of the automatic implantable cardioverter-defibrillator: a preliminary assessment. Health Economics Research group report No. 7, Brunei University, 1990

  • Camm AJ, Anderson M. Letters to the Editor: Life at a price: the implantable defibrillator. British Heart Journal 65: 234, 1991

    Article  PubMed  CAS  Google Scholar 

  • Cardiac Arrhythmia Suppression Trial (CAST) Investigators. Preliminary results: efficacy of encainide and flecainide in a randomized trial of arrhythmia suppression after myocardial infarction. New England Journal of Medicine 321: 406–412, 1989

    Article  Google Scholar 

  • Copien SE, Antman EM, Berlin JA, Hewitt P, Chalmers TC. Clinical investigation: efficacy and safety of quinidine therapy for maintenance of sinus rhythm after cardioversion: a metaanalysis of randomized controlled trials. Circulation 82: 1106–1116, 1990

    Article  Google Scholar 

  • de Buitleir M, Sousa J, Boiling SF, El-Atassi R, Calkins H, et al. Arrhythmias and conduction disturbances: reduction in medical care costs associated with radiofrequency catheter ablation of accessory pathways. American Journal of Cardiology 68: 1656–1661, 1991

    Article  PubMed  Google Scholar 

  • de Buitleir M, Bove EL, Schmaltz S, Kadish AH, Morady F. Arrhythmias and conduction disturbances: cost of catheter versus surgical ablation in the Wolff-Parkinson-White Syndrome. American Journal of Cardiology 66: 189–192, 1990

    Article  PubMed  Google Scholar 

  • Drummond MF, Stoddart GL, Torrance GW. Methods for the economic evaluation of health care programmes. Oxford Medical Publications, Oxford, 1987

    Google Scholar 

  • Ferguson D, Saksena S, Greenberg E, Craelius W. Management of recurrent ventricular tachycardia: economic impact of therapeutic alternatives. American Journal of Cardiology 53: 531–536, 1984

    Article  PubMed  CAS  Google Scholar 

  • Freund DA, Dittus RS. Principles of pharmacoeconomic analysis of drug therapy. PharmacoEconomics 1: 20–31, 1992

    Article  PubMed  CAS  Google Scholar 

  • Kalbfleisch SJ, Calkins H, Langberg JJ, el-Atassi R, Leon A, et al. Comparison of the cost of radiofrequency catheter modification of the atrioventricular node and medical therapy for drug-refractory atrioventricular node reentrant tachycardia. Journal of the American College of Cardiology 19: 1583–1587, 1992

    Article  PubMed  CAS  Google Scholar 

  • Kuppermann M, Luce BR, McGovern B, Podrid PJ, Bigger JT, et al. An analysis of the cost effectiveness of the implantable defibrillator. Circulation 81: 91–100, 1990

    Article  PubMed  CAS  Google Scholar 

  • Larsen GC, Manolis As, Sonnenberg FA, Beshansky JR, Estes NA, et al. Cost-effectiveness of the implantable cardioverterdefibrillator: effect of improved battery life and comparison with amiodarone therapy. Journal of the American College of Cardiology 19: 1323–1334, 1992

    Article  PubMed  CAS  Google Scholar 

  • Lesh MD, Van Hare GF, Schamp dJ, Chien W, Lee MA, et al. Curative percutaneous catheter ablation using radiofrequency energy for accessory pathways in all locations: results in 100 consecutive patients. Journal of the American College of Cardiology 19: 1303–1309, 1992

    Article  PubMed  CAS  Google Scholar 

  • Lezaun R, Brugada P, Smeets J, Talajic M, Trappe HJ, et al. Costbenefit analysis of medical vs surgical treatment of symptomatic patients with accessory atrioventricular pathways. European Heart Journal 10: 1105–1109, 1989

    PubMed  CAS  Google Scholar 

  • Li CK, Shandling AH, Nolasco M, Thomas L, Messenger J, Warren J. Atrial automatic tachycardia-reversion pacemakers: their economic viability and impact on quality-of-life. Pacing and Clinical Electrophysiology 13: 639–645, 1991

    Article  Google Scholar 

  • Mitchell LB, Duff HJ, Miller CE, Eliasoph HP, Wyse DG. Drug therapy of ventricular tachycardia: a cost comparison of randomized noninvasive and invasive approaches. Canadian Journal of Cardiology 8: 487–494, 1992

    PubMed  CAS  Google Scholar 

  • Morganroth J, Bigger JT. Pharmacologic management of ventricular arrhythmias after the Cardiac Arrhythmia Suppression Trial. American Journal of Cardiology 65: 1497–1503, 1990

    Article  PubMed  CAS  Google Scholar 

  • O’Donoghue S, Platia EV, Brooks-Robinson S, Mispireta L. Automatic implantable cardioverter-defibrillator: is early implantation cost-effective? Journal of the American College of Cardiology 16: 1258–1263, 1990

    Article  PubMed  Google Scholar 

  • Podrid PJ, Kowey PR, Frishman WH, Arnold RJG, Kaniecki DJ, et al. Comparative cost-effectiveness analysis of quinidine, procainamide and mexiletine. American Journal of Cardiology 68: 1662–1667, 1991

    Article  PubMed  CAS  Google Scholar 

  • Saksena S, Camm A. Editorial: Implantable defibrillators for prevention of sudden death: technology at a medical and economic crossroad. Circulation 85: 2316–2321, 1991

    Article  Google Scholar 

  • Steinbrook R, Lo B. Oregon Medicaid Demonstration Project — will it provide adequate medical care? New England Journal of Medicine 326: 340–344, 1992

    Article  PubMed  CAS  Google Scholar 

  • Wong JB. Cost-effectiveness analysis. Clinical Decision Analysis-Advanced Syllabus, American College of Physicians, pp. 132–133, Philadelphia, March 25, 1992

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Cardiac Arrhythmia Service, University Hospital, 88 E. Newton Street, Boston, Massachusetts, 02118, USA

    Philip J. Podrid (Director)

  2. Center for Pharmacoeconomic Studies, Pharmacon International Incorporated, New York, New York, USA

    Renée J. G. Arnold & Diana J. Kaniecki

  3. Arnold and Marie Schwartz College of Pharmacy and Health Sciences of Long Island University, Brooklyn, New York, USA

    Renée J. G. Arnold

  4. Rutgers College of Pharmacy, State University of New Jersey, New Brunswick, New Jersey, USA

    Diana J. Kaniecki

Authors
  1. Philip J. Podrid
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Renée J. G. Arnold
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Diana J. Kaniecki
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Podrid, P.J., Arnold, R.J.G. & Kaniecki, D.J. Pharmacoeconomic Considerations in Antiarrhythmic Therapy. PharmacoEconomics 2, 456–467 (1992). https://doi.org/10.2165/00019053-199202060-00006

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00019053-199202060-00006

Keywords

Search

Navigation